GlassScriptPhysician profile
Frank L Tortora
NPI 1912975913
$43,068.40
in general payments reported to CMS, 2019-2025
54 companies · $3,395 in 2025
The $3,395 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,942 · 2020: $10K · 2021: $6,148 · 2022: $6,426 · 2023: $5,862 · 2024: $5,844 · 2025: $3,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $1,831 · Education: $849 · Entertainment: $129 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,167.25 |
| Travel and Lodging | $1,830.70 |
| Education | $849.00 |
| Entertainment | $129.11 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corbin Clinical Resources | $13,000.00 | 2020-2022 | |
| Dendreon Pharmaceuticals LLC | $7,799.21 | 2019-2025 | Provenge |
| Neotract INC. | $4,484.53 | 2019-2020 | |
| Axonics, INC. | $2,978.04 | 2020-2024 | Axonics, Bulkamid |
| Angiodynamics, INC. | $2,764.55 | 2022-2023 | Nanoknife |
| Janssen Biotech, INC. | $2,275.97 | 2019-2025 | Erleada, Akeega, Abiraterone Acetate |
| Sumitomo Pharma America, INC. | $886.91 | 2023-2025 | Gemtesa, Orgovyx |
| Profound Medical Corp. | $833.86 | 2022 | |
| Civco Medical Instruments | $770.27 | 2023-2024 | |
| Astellas Pharma US INC | $660.88 | 2019-2024 | Xtandi |
| Pfizer INC. | $454.36 | 2019-2025 | |
| Teleflex LLC | $450.39 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $437.27 | 2019-2023 | Xiaflex, Aveed |
| Bayer Healthcare Pharmaceuticals INC. | $414.10 | 2021-2025 | |
| Boston Scientific Corporation | $397.56 | 2019-2025 | Axonics, General - Male Sui, Rezum Generator |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $352.66 | 2022-2023 | |
| Myovant Sciences INC. | $313.75 | 2021-2022 | |
| Intuitive Surgical, INC. | $311.92 | 2019-2022 | |
| Olympus America INC. | $253.63 | 2021-2025 | Itind System, Bovie |
| Urogen Pharma, INC. | $237.96 | 2021-2024 | Jelmyto |
| Procept Biorobotics Corporation | $225.75 | 2019-2023 | Aquabeam Robotic System |
| Abbvie INC. | $221.83 | 2022-2025 | Lupron Depot, Botox |
| Merck Sharp & Dohme LLC | $202.23 | 2020-2025 | Lynparza, Keytruda, Welireg |
| Myriad Genetic Laboratories, INC. | $179.70 | 2020-2022 | |
| Antares Pharma, INC. | $172.52 | 2019-2025 | Xyosted |
| Laborie Medical Technologies Corp. | $160.60 | 2023-2025 | Urgent PC Neuromodulation System |
| Convatec INC. | $155.37 | 2022-2023 | |
| Integra Lifesciences Corporation | $147.33 | 2024 | Tenoglide |
| Urovant Sciences INC | $144.83 | 2021-2022 | |
| Blue Earth Diagnostics | $138.89 | 2021-2025 | Posluma |
| Edap Technomed INC | $129.11 | 2025 | |
| Tolmar, INC. | $128.08 | 2023-2025 | Jatenzo, Eligard |
| Ferring Pharmaceuticals INC. | $117.34 | 2019-2025 | Adstiladrin |
| Endo USA, INC. | $89.31 | 2024-2025 | Xiaflex |
| Clarus Therapeutics INC. | $79.35 | 2021 | |
| Amgen INC. | $71.65 | 2020-2021 | |
| Allergan, INC. | $68.21 | 2019-2021 | |
| Abc Home Medical Supply, INC. | $62.66 | 2022 | |
| Genzyme Corporation | $58.48 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $51.62 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $49.53 | 2025 | |
| Verity Pharmaceuticals INC. | $41.28 | 2025 | Tlando, Trelstar |
| Tolmar Pharmaceuticals, INC. | $38.35 | 2020-2022 | |
| Progenics Pharmaceuticals, INC. | $36.92 | 2025 | |
| Acerus Pharmaceuticals Corporation | $32.40 | 2020 | |
| Smith+Nephew, INC. | $31.22 | 2022-2024 | Grafix Pl, Stravix |
| Coloplast Corp | $27.22 | 2019 | |
| Terumo Medical Corporation | $24.93 | 2021 | |
| Ethicon US, LLC | $23.26 | 2019 | |
| Medtronic, INC. | $20.85 | 2024 | Interstim |
| Biogen, INC. | $19.61 | 2022 | |
| Photocure INC | $13.96 | 2022 | |
| Aytu Biopharma, INC. | $13.31 | 2019 | |
| Mission Pharmacal Company | $12.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Tortora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.